Department of Internal Medicine I, University Medical Center Regensburg, Regensburg, Germany.
BMC Musculoskelet Disord. 2010 Jan 27;11:18. doi: 10.1186/1471-2474-11-18.
Pfeifer-Weber-Christian disease (PWCD) is a rare inflammatory disorder of the subcutaneous fatty tissue. The diagnosis and therapy of this rare type of panniculitis is still controversial and will be discussed in this article.
We here report the rare case of a 64-year old male patient, with PWCD. The patient suffered from rheumatoid arthritis for several years, but then developed relapsing fever and recently occurring painful subcutaneous nodules predominantly at the inner part of his left upper limb with no signs of synovitis. Finally, a biopsy from one of the nodules revealed lobular panniculitis with mixed cell infiltrate, which was conformable only with PWCD, after excluding several differential diagnoses. In our patient PWCD developed despite immunosuppressive therapy with steroids and different disease modifying drugs, which the patient received to treat his underlying rheumatoid arthritis. However, when DMARD therapy was switched to Ciclosporin A the patient's symptoms resolved.
Our observation supports the hypothesis that T cells are involved in the pathogenesis of PWCD. Thus, T cell modifying drugs should be primarily used to treat patients with this rare disorder.
Pfeifer-Weber-Christian 病(PWCD)是一种罕见的皮下脂肪组织炎症性疾病。这种罕见类型的脂膜炎的诊断和治疗仍存在争议,本文将对此进行讨论。
我们在此报告一例罕见的 64 岁男性患者,患有 PWCD。该患者患有类风湿关节炎多年,但后来出现反复发作的发热,最近出现左上肢内侧疼痛性皮下结节,无滑膜炎迹象。最后,对其中一个结节进行的活检显示小叶性脂膜炎伴混合细胞浸润,在排除了几种鉴别诊断后,仅符合 PWCD 的诊断。尽管患者接受了类固醇和不同的疾病修正药物(DMARDs)的免疫抑制治疗来治疗其潜在的类风湿关节炎,但 PWCD 仍在发展。然而,当将 DMARD 治疗转换为环孢素 A 时,患者的症状得到缓解。
我们的观察结果支持这样一种假设,即 T 细胞参与了 PWCD 的发病机制。因此,应主要使用 T 细胞修饰药物来治疗这种罕见疾病的患者。